Effects of morbid obesity on insulin clearance and insulin sensitivity in several aspects of metabolism as assessed by low-dose insulin infusion (Q43963805)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 1, 1992

Language	Label	Description	Also known as
English	Effects of morbid obesity on insulin clearance and insulin sensitivity in several aspects of metabolism as assessed by low-dose insulin infusion	scientific article published on June 1, 1992

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Effects of morbid obesity on insulin clearance and insulin sensitivity in several aspects of metabolism as assessed by low-dose insulin infusion (English)

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

author name string

D. A. Robertson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1640847

19 October 2022

B. M. Singh

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1640847

19 October 2022

P. J. Hale

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1640847

19 October 2022

M. Nattrass

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1640847

19 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1640847

19 October 2022

publication date

1 June 1992

1 reference

Europe PubMed Central

28 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:002604959290052C?httpAccept=text/xml

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

https://api.elsevier.com/content/article/PII:002604959290052C?httpAccept=text/plain

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

1 reference

Europe PubMed Central

28 November 2017

41

1 reference

Europe PubMed Central

28 November 2017

6

1 reference

Europe PubMed Central

28 November 2017

604-612

1 reference

Europe PubMed Central

28 November 2017

Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay

1

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The Significance of Basal Insulin Levels in the Evaluation of the Insulin Response to Glucose in Diabetic and Nondiabetic Subjects*

2

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Quantitative study of insulin secretion and clearance in normal and obese subjects

3

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Blood Pyruvate and Lactate Levels during Oral and Intravenous Glucose Tolerance Tests in Diabetes Mellitus

4

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Splanchnic glucose and amino acid metabolism in obesity

5

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Insulin secretion in obesity

6

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.

8

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects

9

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects

10

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

A Simplified Method Using Somatostatin to Assess In Vivo Insulin Resistance over a Range of Obesity

11

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The Antilipolytic Action of Insulin in Obese Subjects with Resistance to Its Glucoregulatory Action*

12

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique.

13

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus

14

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Blood pyruvate and plasma glucose levels during oral and intravenous glucose tolerance tests in obese and non-obese women

16

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Metabolic abnormalities in obese patients with impaired glucose tolerance

17

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Dose response to insulin in man: differential effects on glucose and ketone body regulation

18

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Insulin regulation of lipolysis in nondiabetic and IDDM subjects

19

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The effects of a low-dose intravenous insulin infusion upon plasma glucose and non-esterified fatty acid levels in very obese and non-obese human subjects.

20

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Differences in insulin sensitivity between normal men and women.

21

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Following weight loss in massively obese patients correction of the insulin resistance of fat metabolism is delayed relative to the improvement in carbohydrate metabolism

22

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Use of combined oral contraceptive preparations alters the insulin sensitivity of fatty acid and ketone metabolism.

23

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Immunoassay of insulin with insulin-antibody precipitate

28

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Glucose turnover values in the dog obtained with various species of labeled glucose

29

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity

32

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Calculating confidence intervals for regression and correlation.

34

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Decreased insulin removal contributes to hyperinsulinemia in obesity.

36

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Reduced Hepatic Insulin Extraction in Obesity: Relationship with Plasma Insulin Levels

37

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Decreased hepatic insulin extraction in subjects with mild glucose intolerance.

38

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations

39

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics

40

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Experimental validation of measurements of glucose turnover in nonsteady state

43

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Relationship between total body water and surface area in normal and obese subjects

45

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Impaired insulin action in newly diagnosed type 1 (insulin-dependent) diabetes mellitus

46

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

A Comparison of the Relative Effects of Obesity and Non-insulin-dependent Diabetes Mellitus on In Vivo Insulin-stimulated Glucose Utilization

47

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity

48

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

49

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Obesity and insulin resistance in humans: a dose-response study.

50

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Effect of time on measurement of hepatic glucose production

51

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The metabolic clearance of glucose: measurement and meaning

52

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The physiologic action of insulin on glucose uptake and its relevance to the interpretation of the metabolic clearance rate of glucose

53

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Differential effect of steady-state hyperinsulinaemia and hyperglycaemia on hepatic glycogenolysis and glycolysis in rats

54

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Differential effects of IGF-I and insulin on glucoregulation and fat metabolism in depancreatized dogs

55

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The glucose-alanine cycle

56

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Influence of hyperinsulinaemia on intracellular amino acid levels and amino acid exchange across splanchnic and leg tissues in uraemia

57

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans

58

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Lessons from studies of insulin pharmacokinetics

59

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans

60

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.

61

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The roles of insulin, glucagon, and free fatty acids in the regulation of ketogenesis in dogs

63

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Elevated Pancreatic Glucagon in Obesity

64

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation

66

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

The Metabolic Effects of Biosynthetic Human Proinsulin in Individuals with Type I Diabetes*

67

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms

68

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor

71

1 reference

10.1016/0026-0495(92)90052-C

https://api.crossref.org/works/10.1016/0026-0495(92)90052-C

19 October 2022

Identifiers

10.1016/0026-0495(92)90052-C

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43963805&oldid=1754565720"